INSIDERTERMINAL

High-Impact Form 4 Intelligence

Real-time SEC insider trading data with advanced filtering. Free beta.

💬 Give Feedback

Total Buys (Filtered)

$0

$0

Total Sells (Filtered)

$8.7M

$8,657,405

View Raw Line-Items

Live Feed: 2026-03-11

Timeline

Side

Size

All $1M+ $5M+ $10M+

Role

Ticker Search

Clear Clear Filters

Ticker	Company	Reporting Owner	Date	Value (USD)	Type	Form 4
APGE S Apogee Therapeutics, Inc. HENDERSON MICHAEL THOMAS • CEO 10b5-1 Sell 2026-02-11 $1,266,953Largex3 View Form 4 →
APGE	Apogee Therapeutics, Inc.	HENDERSON MICHAEL THOMAS CEO 10b5-1 Sell	2026-02-11	$1,266,953Largex3	S	Form 4
APGE S Apogee Therapeutics, Inc. HENDERSON MICHAEL THOMAS • CEO 10b5-1 Sell 2026-01-14 $1,622,159Largex6 View Form 4 →
APGE	Apogee Therapeutics, Inc.	HENDERSON MICHAEL THOMAS CEO 10b5-1 Sell	2026-01-14	$1,622,159Largex6	S	Form 4
APGE S Apogee Therapeutics, Inc. HENDERSON MICHAEL THOMAS • CEO 10b5-1 Sell 2025-12-10 $1,507,657Largex3 View Form 4 →
APGE	Apogee Therapeutics, Inc.	HENDERSON MICHAEL THOMAS CEO 10b5-1 Sell	2025-12-10	$1,507,657Largex3	S	Form 4
APGE S Apogee Therapeutics, Inc. HENDERSON MICHAEL THOMAS • CEO 10b5-1 Sell 2025-12-04 $3,000,400Large View Form 4 →
APGE	Apogee Therapeutics, Inc.	HENDERSON MICHAEL THOMAS CEO 10b5-1 Sell	2025-12-04	$3,000,400Large	S	Form 4
APGE S Apogee Therapeutics, Inc. HENDERSON MICHAEL THOMAS • CEO 10b5-1 Sell 2025-11-13 $1,260,236Largex4 View Form 4 →
APGE	Apogee Therapeutics, Inc.	HENDERSON MICHAEL THOMAS CEO 10b5-1 Sell	2025-11-13	$1,260,236Largex4	S	Form 4